Pathogenesis of non-insulin-dependent (type II) diabetes mellitus (NIDDM) - Genetic predisposition and metabolic abnormalities

Advanced Drug Delivery Reviews

Volumn 35, Issue 2-3, 1999, Pages 157-177

  Jun, Hee Sook ^a   Bae, Hak Yeon ^a,b   Lee, Byoung Rai ^a,b   Koh, Kwang Sam ^b   Kim, Young Soo ^c   Lee, Kwan Woo ^d   Kim, Hyun man ^d   Yoon, Ji Won ^a,d  

^a UNIVERSITY OF CALGARY   (Canada)

^b Chosun University   (South Korea)

^c Eastwood Biomed Research Institute   (Canada)

^d Lab Endocrinol Diabet Res C   (South Korea)

Author keywords

Defects in insulin secretion; Environmental factors; Genetic susceptibilities; Hyperglycemia; Insulin resistance; Metabolic abnormalities

Indexed keywords

GLUCOSE; INSULIN;

AGING; DIABETIC ANGIOPATHY; DIABETIC NEUROPATHY; DIET; ENVIRONMENTAL FACTOR; ETHNIC GROUP; FAMILIAL DISEASE; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GLUCOSE HOMEOSTASIS; HUMAN; HYPERGLYCEMIA; INSULIN RELEASE; INSULIN RESISTANCE; METABOLIC DISORDER; MICROVASCULATURE; MONOZYGOTIC TWINS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOGENESIS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; STRESS;

EID: 0032969537     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(98)00071-4     Document Type: Review

References (229)

1. World Health Organization Study Group, Diabetes mellitus, WHO Tech. Rep. Ser. 727 (1985) 1-113.
2. J.W. Yoon, H.S. Jun, Insulin-dependent diabetes mellitus, in: M.M. Roitt, P.J. Delves (Eds.), Encyclopedia of Immunology, 2nd ed., Academic Press, London (1998) pp. 1390-1398.
3. Bach J.F. Insulin-dependent diabetes mellitus as a β cell targeted disease of immunoregulation. J. Autoimmun. 8:1995;439-463.
4. Yki-Järvinen H. Pathogenesis of non-insulin-dependent diabetes mellitus. Lancet. 343:1994;91-95.
5. DeFronzo R.A. The triumvirate: β-cell, muscle, liver: a collusion responsible for NIDDM. Diabetes. 37:1988;667-687.
6. Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4400 patients observed between 1947 and 1973. Diabetes Care. 1:1978;168-188.
7. S.S. Fajans, J.W. Conn, Prediabetes, subclinical diabetes, and latent clinical diabetes: interpretation, diagnosis and treatment, in: D.S. Leibel, G.S. Wrenshall (Eds.), On the Nature and Treatment of Diabetes, Excerpta Medica, Amsterdam, 1965, pp. 641-656.
8. Ghosh S., Schork N. Genetic analysis of NIDDM. Diabetes. 45:1995;1-14.
9. Kobberling J. Studies on the genetic heterogeneity of diabetes mellitus. Diabetologia. 7:1971;46-49.
10. J.L. Rotter, C.M. Vadheim, D.L. Rimoin, Genetics of diabetes mellitus, in: H. Rifkin, D. Porte (Eds.), Diabetes Mellitus Theory and Practice, Elsevier, New York, 1990, pp. 378-413.
11. O'Rahilly S., Wainscoat J.S., Turner R.C. Type 2 (noninsulin dependent) diabetes mellitus. New genetics for old nightmares. Diabetologia. 31:1988;407-414.
12. Barnett A.H., Eff C., Leslie R.D.G., Pyke D.A. Diabetes in identical twins. A study of 200 pairs. Diabetologia. 20:1981;87-93.
13. Knowler W.C., Williams R.C., Pettitt D.J., Steinberg A.G. Gm and type 2 diabetes mellitus: an association in American Indians with genetic admixture. Am. J. Hum. Genet. 43:1988;520-526.
14. P.H. Bennett, C. Bogardus, J. Tuomilehto, P. Zimmett, Epidemiology and natural history of NIDDM: non-obese and obese, in: K.G.M.M. Alberti, R.A. DeFronzo, H. Keen, P. Zimmett (Eds.), International Textbook of Diabetes Mellitus, Wiley, New York, 1992, pp. 147-176.
15. Helmrich S.P., Ragland D.R., Leung R.W., Paffenbarger R.S. Jr. Physical activity and reduced occurrence of NIDDM. N. Engl. J. Med. 325:1991;147-152.
16. Saad M.F., Knowler W.C., Pettitt D.J., Nelson R.G., Charles M.A., Bennett P.H. A two step model for development of non-insulin-dependent diabetes. Am. J. Med. 90:1991;229-235.
17. DeFronzo R.A., Bonadonna R.C., Ferrannini E. Pathogenesis of NIDDM: a balanced overview. Diabetes Care. 15:1992;318-368.
18. Lillioja S., Mott D.M., Spraul M., Ferraro R., Foley J.E., Ravussin E., Knowler W.C., Bennett P.H., Bogardus C. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. N. Engl. J. Med. 329:1993;1988-1992.
19. Knowler W.C., Pettitt D.J., Saad M.F., Bennett P.H. Diabetes mellitus in Pima Indians: incidence, risk factors and pathogenesis. Diabetes Metab. Rev. 6:1990;1-27.
20. Flegal K.M., Ezzati T.M., Harris M.I., Haynes S.G., Juarez R.Z., Knowler W.C., Perez-Stable E.J., Stern M.P. Prevalence of diabetes in Mexican-Americans, Cubans, and Puerto Ricans from the Hispanic Health and Nutrition Examination Survey 1982-1984. Diabetes Care. 14:1991;628-638.
21. Newman B., Selby J.V., King M.C. Concordance for Type II (non-insulin-dependent) diabetes mellitus in male twins. Diabetes. 30:1987;363-368.
22. Gottlieb M.S. Diabetes in offspring and siblings of juvenile- and maturity-onset type II diabetics. J. Chronic Dis. 33:1980;331-338.
23. Kahn C.R. Insulin action, diabetogenes, and the cause of Type II diabetes (Banting lecture). Diabetes. 43:1994;1066-1074.
24. Steiner D.F., Tager H.S., Chan S.J., Nanjo K., Rubenstein A.H., Sanke T. Lessons learned from molecular biology of insulin-gene mutation. Diabetes Care. 13:1990;600-609.
25. Kahn C.R., Vicent D., Doria A. Genetics of non-insulin-dependent (Type II) diabetes mellitus. Annu. Rev. Med. 47:1996;509-531.
26. Given B.D., Mako M.E., Tager H.S., Baldwin D., Markese J., Rubenstein A.H., Olefsky J., Kobayashi M., Kolterman O., Poucher R. Familial hypoproinsulinemia due to a proposed defect in conversion of proinsulin to insulin. N. Engl. J. Med. 302:1980;129-135.
27. Nanjo K., Sanke T., Miyano M., Okai K., Sowa R., Kondo M., Nishimura S., Iwo K., Miyamura K., Given B.D., Chan S.J., Tager H.S., Steiner D.F., Rubenstein A.H. Diabetes due to secretion of a structurally abnormal insulin (insulin Wakayama). Clinical and functional characteristics of [Leu A3] insulin. J. Clin. Invest. 77:1986;514-519.
28. Shoelson S.E., Polonsky K.S., Zeidler A., Rubenstein A.H., Tager H.S. Human insulin B24 (Phe→Ser). Secretion and metabolic clearance of the abnormal insulin in man and in a dog model. J. Clin. Invest. 73:1984;1351-1358.
29. Robbins D.C., Blix P.M., Rubenstein A.H., Kanazawa Y., Kosaka K., Tager H.S. A human proinsulin variant at arginine 65. Nature. 291:1981;679-681.
30. Yano H., Kitano N., Morimoto M., Polonsky K.S., Imura H., Seino Y. A novel point mutation in the human insulin gene giving rise to hyperproinsulinemia (proinsulin Kyoto). J. Clin. Invest. 89:1993;1902-1907.
31. Warren-Perry M.G., Manley S.E., Ostrega D., Polonsky K., Mussett S., Brown P. A novel point mutation in the insulin gene giving rise to hyperproinsulinemia. J. Clin. Endocrinol. Metab. 82(5):1995;1629-1631.
32. Gruppuso P., Gorden P., Kahn C.R. Familial hyperproinsulinemia due to a proposed defect in conversion of proinsulin to insulin. N. Engl. J. Med. 311:1984;629-634.
33. Mueckler M. Facilitative glucose transporters. Eur. J. Biochem. 219:1994;713-725.
34. Fukumoto H., Seino S., Imura H. Sequence, tissue distribution and chromosomal localization of mRNA encoding a human glucose transporter-like protein. Proc. Natl. Acad. Sci. USA. 85:1988;5434-5438.
35. Matsutani A., Koranyi L., Cox N., Permutt M.A. Polymorphisms of GLUT-2 and GLUT genes: use in evaluation of genetic susceptibility to NIDDM in blacks. Diabetes. 39:1990;1534-1542.
36. Elbein S.C., Hoffman M.D., Matsutani A., Permutt M.P. Linkage analysis of GLUT-1 (HepG2) and GLUT-2 (liver/islet) genes in familial NIDDM. Diabetes. 41:1992;1660-1667.
37. Baroni M.G., Alcolado J.C., Pozzilli P., Cavallo M.G., Li S-R., Galton D.J. Polymorphisms at the GLUT-2 (β-cell/liver) glucose transporter gene and non-insulin-dependent diabetes mellitus (NIDDM): analysis in affected pedigree members. Clin. Genet. 41:1992;229-234.
38. Mueckler M., Kruse M., Strube M., Riggs A.C., Chiu K.C., Permutt M.A. A mutation of the Glut2 glucose transporter gene of a diabetic patient abolishes transport activity. J. Biol. Chem. 269:1994;17765-17767.
39. Tanizawa Y., Riggs A.C., Chiu K.C., Janssen R.C., Bell D.S., Go R.P., Roseman J.M., Acton R.T., Permutt M.A. Variability of the pancreatic islet beta cell/liver (GLUT-2) glucose transporter gene in NIDDM patients. Diabetologia. 37:1994;420-427.
40. Matschunsky F., Liang Y., Kesavan P., Wang L., Froguel P., Velho G., Cohen D., Permutt M.A., Tanizawa Y., Jetton T.L., Niswender K., Magnuson M.A. Glucokinase as pancreatic β-cell glucose sensor and diabetes gene. J. Clin. Invest. 92:1993;2092-2098.
41. Froguel P.H., Vaxillaire M., Sun F., Vilho G., Zouali H., Butel M.O., Lesage S., Bionnet N., Clement K., Fougerousse F., Tanizawa Y., Weissenbach J., Beckmann J.S., Laathrop G.M., Passa Ph., Permutt M.A., Cohen D. Close linkage of glucokinase locus on chromosome 7p to early onset non-insulin-dependent diabetes mellitus. Nature. 356:1992;162-164.
42. Hattersley A.T., Turner R.C., Permutt M.A., Patel P., Tanizawa Y., Chiu K.C., O'Rahilly S., Watkins P.J., Wainscoat J.S. Linkage of type 2 diabetes to the glucokinase gene. Lancet. 339:1992;1307-1310.
43. Froguel P., Zouali H., Vionnet N., Velho G., Vaxillaire M., Sun F., Lesage S., Stoffel M., Takeda J., Passa Ph., Permutt M.A., Beckmann J.S., Bell G.I., Cohen D. Familial hyperglycemia due to mutations in glucokinase: definition of a subtype of diabetes mellitus. N. Engl. J. Med. 328:1993;697-702.
44. Janssen R.C., Bogardus C., Takeda J., Knowler W.C., Thompson D.B. Linkage analysis of acute insulin secretion with GLUT-2 and glucokinase in Pima Indians and the identification of a missense mutation in GLUT-2. Diabetes. 43:1994;558-563.
45. Cook J.T.E., Hattersley A.T., Christopher P., Bown E., Barrow B., Patel P., Shaw J.A.G., Cookson W.O.C.M., Permutt M.A., Turner R.C. Linkage analysis of glucokinase gene with NIDDM in Caucasian pedigrees. Diabetes. 41:1992;1496-1500.
46. Elbein S.C., Hoffman M., Chiu K., Tanizawa Y., Permutt M.A. Linkage analysis of the glucokinase locus in familial type 2 (non-insulin-dependent) diabetic pedigrees. Diabetologia. 36:1993;141-145.
47. Bell G.I., Xiang K-S., Newman M.V., Wu S-H., Wright L.G., Fajans S.S., Spielman R.S., Cox N.J. Gene for non-insulin-dependent diabetes mellitus (maturity-onset diabetes of the young subtype) is linked to DNA polymorphism on human chromosome 20q. Proc. Natl. Acad. Sci. USA. 88:1991;1484-1488.
48. Bowden D.W., Gravius T.C., Akots G., Fajans S.S. Genetic markers flanking the maturity-onset diabetes of the young locus on human chromosome 20. Diabetes. 41:1992;88-92.
49. Rothschild C.B., Akots G., Hayworth R., Pettenati M.J., Rao P.N., Wood P., Solz F-M., Hansmann I., Serino K., Keith T.P., Fajans S.S., Bowden D.W. A genetic map of chromosome 20q12-q13.1: multiple highly polymorphic microsatellite and RFLP markers linked to the maturity onset diabetes of the young (MODY) locus. Am. J. Hum. Genet. 52:1993;110-123.
50. Patel P., Dennis Lo Y-M., Hattersley A., Bell G.I., Tybjaerg-Hansen A., Nerup J., Turner R.C., Wainscoat J.S. Linkage analysis of maturity-onset diabetes of the young with microsatellite polymorphisms: no linkage to ADA or GLUT-2 genes in two families. Diabetes. 41:1992;962-967.
51. Baroni M.G., Alcolado J.C., Needham E.W.A., Pozzilli P., Stocks J., Galton D.J. Sib-pair analysis of adenosine deaminase locus in NIDDM. Diabetes. 41:1992;1640-1643.
52. Vaxillaire M., Boccio V., Philippi A. A gene for maturity onset diabetes of the young maps to chromosome 12q. Nature Genet. 9:1995;418-423.
53. Gerbitz K.D. Does the mitochondrial DNA play a role in the pathogenesis of diabetes? Diabetologia. 35:1992;1181-1186.
54. Yousufzai S.Y., Bradford M.W., Shrago E., Ewart R.B. Characterization of the adenine nucleotide translocate of pancreatic islet mitochondria. FEBS Lett. 137:1982;205-208.
55. Schulz J.B., Klockgether T., Dichgans J. Mitochondrial gene mutations and diabetes mellitus (letter). Lancet. 341:1993;438-439.
56. Sue C.M., Holmes-Walker D.J., Moriss J.G.L. Mitochondrial gene mutations and diabetes mellitus (letter). Lancet. 341:1993;437-438.
57. Reardon W., Ross R.J., Sweeney M.G. Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet. 340:1992;1376-1379.
58. Alcolado J.C., Majid A., Brockington M. Mitochondrial gene defects in patients with NIDDM. Diabetologia. 37:1994;372-376.
59. Kobayashi Y., Nomoi M.Y., Tominaga K. Respiratory deficient cells are caused by a single point mutation in the mitochondrial tRNA-Leu(UUR) gene in mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Am. J. Hum. Genet. 49:1991;590-599.
60. Suzuki S., Hinokio Y., Hirai S., Onada M., Matsumoto M., Ohtomo M., Kawasaki H., Satoh Y., Akai H., Abe K., Miyabayashi S., Kawasaki E., Nagataki E., Toyota T. Pancreatic β-cell secretory defect associated with mitochondrial point mutation of the tRNA Leu(UUR) gene: a study in seven families with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS). Diabetologia. 37:1994;818-825.
61. Vionnet N., Passa P., Froguel P. Prevalence of mitochondrial gene mutations in families with diabetes mellitus. Lancet. 342:1993;1429-1430.
62. Leu(UUR) gene mutation in Japanese patients. Diabetologia. 37:1994;504-510.
63. F. Thomas, B. Balkau, F. Vauzelle-Kervroedan, L. Papoz, the Codiab-Inserm-Zeneca Study Group, Maternal effect and familial aggregation in NIDDM, Diabetes 43 (1994) 63-67.
64. Van den Ouweland J.M.W., Lemkes H.H.P.J., Trembath R.C. Maternally inherited diabetes and deafness is a distinct subtype of diabetes and associates with a single point mutation in the mitochondrial tRNA Leu(UUR) gene. Diabetes. 43:1994;746-751.
65. Ballinger S.W., Shoffner J.M., Hedaya E.V., Trounce I., Polak M.A., Koontz D.A., Wallace D.C. Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion. Nature Genet. 1(1):1992;11-15.
66. Dunbar D.R., Moonie P.A., Swingler R.J., Davidson D., Roberts R., Holt I.J. Maternally transmitted partial direct tandem duplication of mitochondrial DNA associated with diabetes mellitus. Hum. Mol. Genet. 2:1993;1619-1624.
67. Rotig A., Cormier V., Chatelain P., Francois R., Saudubray J.M., Rustin P., Munnich A. Deletion of mitochondrial DNA in a case of early-onset diabetes mellitus, optic atrophy, and deafness (Wolfram syndrome, MIM 222300). J. Clin. Invest. 91:1993;1095-1098.
68. Lok S., Kuijper J.L., Jelinek W. The human glucagon receptor encoding gene: structure, cDNA sequence and chromosomal localization. Gene. 140:1994;203-209.
69. Hager J., Hansen L., Vaisse C., Vionnet N., Philippi A., Poller W., Velho G., Carcassi C., Contu L., Julier C. A missense mutation in the glucagon receptor gene is associated with non-insulin-dependent diabetes mellitus. Nature Genet. 9:1995;299-304.
70. Orskov C. Glucagon-like peptide-1, a new hormone of the entero-insular axis. Diabetologia. 35:1992;701-711.
71. Nauck M.A., Heimesaat M.M., Orskov C., Holst J.J., Ebert R., Creutzfeldt W. Preserved incretin activity of glucagon-like peptide 1 [7-36] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J. Clin. Invest. 91:1993;301-307.
72. Drucker D.J., Philippe J., Mojsov S., Chick W.L., Habener J.F. Glucagon-like peptide-1 stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Proc. Natl. Acad. Sci. 84:1987;3434-3438.
73. Orskov C., Jeppesen J., Madsbad S., Holst J.J. Proglucagon products in plasma of non-insulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine. J. Clin. Invest. 87:1991;415-423.
74. Tanizawa Y., Riggs A.C., Elbein S.C., Whelan A., Donnis-Keller H., Permutt M.A. Human glucagon-like peptide-1 receptor gene in NIDDM: identification and use of simple sequence repeat polymorphisms in genetic analysis. Diabetes. 143:1994;752-757.
75. Taylor S.I. Lilly Lecture: molecular mechanisms of insulin resistance - lessons from patients with mutations in the insulin receptor gene. Diabetes. 41:1992;1473-1490.
76. Flier J.S. Lilly Lecture: syndromes of insulin resistance. From patient to gene and back again. Diabetes. 41:1992;1207-1219.
77. Nozaki O., Suzuki Y., Shimada F., Hashimoto N., Taira M., Hatanaka Y., Notoya Y., Kanashiro O., Makino H., Yoshida S. A glycine-1008 to valine mutation in the insulin receptor in a woman with Type A insulin resistance. J. Clin. Endocrinol. Metab. 77:1993;169-172.
78. Roach P., Zick Y., Formisano P., Accili D., Taylor S.I., Gorden P. A novel human insulin receptor gene mutation uniquely inhibits insulin binding without impairing post-translational processing. Diabetes. 43:1994;1096-1102.
79. Krook A., Kumar S., Laing I., Boulton A.J.M., Wass J.A.H., O'Rahilly S. Molecular scanning of the insulin receptor gene in syndromes of insulin resistance. Diabetes. 43:1994;357-368.
80. Cama A., Sierra M.L., Kadowaki T., Quon M.J., Rudiger H.W., Dreyer M., Taylor S.I. Two mutant alleles of the insulin receptor gene in a family with a genetic form of insulin resistance: a 10 base pair deletion in exon 1 and a mutation substituting serine for asparagine-462. Hum. Genet. 95:1995;174-182.
81. McClain R.A., Henry R.R., Ullrich A., Olefsky J.M. Restriction fragment length polymorphism in insulin receptor gene and insulin resistance in NIDDM. Diabetes. 37:1986;1071-1075.
82. O'Rahilly S., Choi W.H., Patel P., Turner R.C., Flier J.S., Moller D.E. Detection of mutations in insulin-receptor gene in NIDDM by analysis of single-stranded conformation polymorphisms. Diabetes. 40:1991;777-782.
83. Elbein S.C., Sorensen L.K., Taylor M. Linkage analysis of insulin receptor gene in familial NIDDM. Diabetes. 41:1992;648-656.
84. Moller D.E., Yokota A., Flier J.S. Normal insulin receptor cDNA sequence in Pima Indians with NIDDM. Diabetes. 38:1989;1496-1500.
85. Cama A., Patterson A.P., Kadowaki T., Kadowaki H., Siegel G., D'Ambrosio D., Lillioja S., Roth J., Taylor S.I. The amino acid sequence of the insulin receptor is normal in an insulin resistant Pima Indian. J. Clin. Endocrinol. Metab. 70:1990;1155-1161.
86. Kusari J., Verma U.S., Buse J.B., Henry R.R., Olefsky J.M. Analysis of the gene sequences of the insulin receptor and the insulin-sensitive glucose transporter (GLUT-4) in patients with common type non-insulin-dependent diabetes mellitus. J. Clin. Invest. 88:1991;1323-1330.
87. Clark A., Cooper G.J.S., Lewis C.E., Morris J.F., Willis A.C., Reid K.B., Turner R.C. Islet amyloid formed from diabetes-associated peptide may be pathogenic in type 2 diabetes. Lancet. 2:1987;231-234.
88. Johnson K.H., O'Brien T.D., Betholtz C., Westermark P. Islet amyloid, islet-amyloid polypeptide, and diabetes mellitus. N. Engl. J. Med. 321:1989;513-518.
89. Mosselman S., Hoppener J.W.M., Zandberg J., van Mansfeld A.D., Guerts van Kessel A.H., Lips C.J., Jansz H.S. Islet amyloid polypeptide: identification and chromosomal localization of the human gene. FEBS Lett. 239:1988;227-232.
90. Cook J.T.E., Patel P.P., Clark A., Höppener J.W.M., Lips C.J.M., Mosselman S., O'Rahilly S., Page R.C., Wainscoat J.S., Turner R.C. Non-linkage of the islet amyloid polypeptide gene with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 34:1991;103-108.
91. Nishi M., Bell G.I., Steiner D.F. Islet amyloid polypeptide (amylin): no evidence of an abnormal precursor sequence in 25 type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 33:1990;628-630.
92. Stoffel M., Espinosa R., Keller S.R., Lienhard G.E., LeBeau M.M., Bell G.I. Human insulin receptor substrate-1 gene (IRS1): chromosomal localization to 2q35-q36.1 and identification of a simple tandem repeat DNA polymorphism. Diabetologia. 36:1993;335-337.
93. Almind K., Bjorbaek C., Vestergaard H., Hansen T., Echwald S., Pedersen O. Amino acid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet. 342:1993;828-832.
94. Hager J., Zouali H., Velho G., Froguel P. Insulin receptor substrate (IRS-1) gene polymorphisms in French NIDDM families. Lancet. 342:1993;1430.
95. Shipman P., Kammerer C., O'Connell P., Stern M. Insulin receptor substrate-1 is not linked to type II diabetes in Mexican Americans. Diabetes. 43(Suppl.):1994;168A.
96. Oelbaum R.S. Analysis of three glucose transporter genes in a Caucasian population: no associations with non-insulin-dependent diabetes and obesity. Clin. Genet. 42:1992;260-266.
97. Matsutani A., Korany L., Cox N., Permutt M.A. Polymorphisms of GLUT-2 and GLUT-4 genes. Use in evaluation of genetic susceptibility to NIDDM in Blacks. Diabetes. 39:1990;1534-1542.
98. Baroni M.G., Oelbaum R.S., Pozzilli P., Stocks J., Li S.R., Fiore V., Galton D.J. Polymorphisms at the GLUT-1 (HepG2) and GLUT-4 (muscle/adipocyte) glucose transporter genes and non-insulin-dependent diabetes mellitus (NIDDM). Hum. Genet. 88:1992;557-561.
99. Cox N.J., Xiang K.S., Bell G.I., Karam J.H. Glucose transporter gene and non-insulin-dependent diabetes. Lancet. 2:1988;793-794.
100. Kaku K., Matsutani A., Mueckler M., Permutt M.A. Polymorphisms of HepC2/erythrocyte glucose transporter gene. Diabetes. 39:1990;49-56.
101. Groop L.C., Bonadonn R.C., DelPrato S., Ratheiser K., Zyck K., Ferrannini E., DeFronzo R.A. Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus: evidence for multiple sites of insulin resistance. J. Clin. Invest. 84:1987;205-213.
102. Thorburn A.W., Gumbiner B., Bulacan F., Brechtel G., Henry R.R. Multiple defects in muscle glycogen synthase activity contribute to reduced glycogen synthesis in non-insulin-dependent diabetes mellitus. J. Clin. Invest. 87:1991;490-495.
103. Vaag A., Henriksen J.E., Beck-Nielsen H. Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first degree relatives of patients with non-insulin-dependent diabetes mellitus. J. Clin. Invest. 89:1992;782-788.
104. Lehto M., Stoffel M., Groop L. Assignment of the gene encoding glycogen synthase (GSY) to human chromosome 19, band q13.3. Genomics. 15:1993;460-461.
105. Groop L.C., Kankura M., Schalin-Jantti C., Ekstrand A., Nikula-Ijas P., Widen E., Kuismanen E., Eriksson J. Association between polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. N. Engl. J. Med. 328:1993;10-14.
106. Kadowaki T., Kadowaki H., Yazaki Y. Polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. N. Engl. J. Med. 328:1993;1568-1569.
107. Kuroyama H., Sanke T., Ohagi S., Furuta M., Furuta H., Nanjo K. Simple tandem repeat DNA polymorphism in the human glycogen synthase gene is associated with NIDDM in Japanese subjects. Diabetologia. 37:1994;536-539.
108. Widen E., Lehto M., Kanninen T., Walston J., Shuldiner A.R., Groop L.C. Association of a polymorphism in the β3-adrenergic receptor gene with features of the insulin resistance syndrome in Finns. N. Engl. J. Med. 333:1995;348-351.
109. Walston J., Silver K., Bogardus C., Knowler W.C., Celi F.S., Austin S., Manning B., Strosberg A.D., Stern M.P., Raben N., Sorkin J.D., Roth J., Shuldiner A.R. Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the β3-adrenergic receptor gene. N. Engl. J. Med. 333:1995;343-347.
110. Kadowaki H., Kazuki Y., Iwamoto K., Otabe S., Shimokawa K., Silver K., Walston J., Yoshinaga H., Kosaka K., Yamada N., Saito Y., Hagura R., Akanuma Y., Shuldiner A., Yazaki Y., Kadowaki T. A mutation in the β3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem. Biophys. Res. Commun. 215:1995;555-560.
111. Clement K., Vaisse C., Manning B.S.-J., Basdevant A., Guy-Grand B., Ruiz J., Silver K.D., Shuldiner A.R., Froguel P., Strosberg A.D. Genetic variation in the β3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N. Engl. J. Med. 333:1995;352-354.
112. Permutt M.A., Chiu K.C., Tanizawa Y. Glucokinase and NIDDM: a candidate gene that paid off. Diabetes. 41:1992;1367-1372.
113. Zouali H., Vaxillaire M., Lesage S., Sun G., Velho V., Vionnet K., Chiu P., Passa P., Permutt A., Demenais F., Cohen D., Beckmann J.S., Froguel P. Linkage analysis and molecular scanning of glucokinase gene in NIDDM families. Diabetes. 42:1993;1238-1245.
114. 142→His substitution. Diabetes. 44:1995;340-346.
115. Echwald S.M., Bjorbaek C., Hansen T. Identification of four amino acid substitutions in hexokinase II and studies of relationships to NIDDM, glucose effectiveness and insulin sensitivity. Diabetes. 44:1995;347-353.
116. Prochazka M., Lillioja S., Tait J.F. Linkage of chromosomal markers on 4q with a putative gene determining maximal insulin action in Pima Indians. Diabetes. 42:1993;514.
117. Stern M.P., Haffner S.M. Type II diabetes and its complications in Mexican Americans. Diabetes Metab. Rev. 6:1990;29-45.
118. Humphreys P., McCarthy M., Tuomilehto J., Tuomilehto-Wolf E., Stratton I., Morgan R., Rees A., Owens D. Chromosome 4q locus associated with insulin resistance in Pima Indians: studies in three European NIDDM populations. Diabetes. 43:1994;800-804.
119. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse gene and its human homologue. Nature. 372:1994;425-432.
120. Considine R.V., Cosidine E.L., Williams C.J., Nyce M.R., Magosin S.A., Bauer T.L., Rosato E.L., Colberg J., Caro J.F. Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity. J. Clin. Invest. 95:1995;2986-2988.
121. Maffei M., Halaas J., Ravussin E., Pratley R.E., Lee G.H., Zhang Y., Fei H., Kim S., Lallone R., Ranganathan S., Kern P.A., Friedman J.M. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Medicine. 10:1995;1155-1161.
122. Lonnqvist F., Arner P., Nordfors L., Schalling M. Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nature Medicne. 1:1995;950-953.
123. Smeekens S.P., Steiner D.F. Post-translational proteolysis in polypeptide hormone biosynthesis. Annu. Rev. Physiol. 44:1982;625-638.
124. Yoshioka N., Kuzuya T., Matsuda A., Taniguchi M., Iwamoto Y. Serum proinsulin levels at fasting and after oral glucose load in patients with type II (non-insulin-dependent) diabetes mellitus. Diabetologia. 31:1988;355-360.
125. Rhodes C.J., Alarcon C. What β-cell defect could lead to hyperproinsulinemia in NIDDM? Some clues from recent advances made in understanding the proinsulin-processing mechanism. Diabetes. 43:1994;511-517.
126. Naggert J.K., Fricker L.D., Varlamov O., Nishina P.M., Rouille Y., Steiner D.F., Carroll R.J., Paijen B.J., Leiter E.H. Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity. Nature Genet. 10:1995;135-142.
127. Ohagi S., LaMendola J., LeBeau M.M., Espinosa III R., Takeda J., Smeekens S.P., Chan S.J., Steiner D.F. Identification and analysis of the gene encoding human PC2, a prohormone convertase expressed in neuroendocrine tissues. Proc. Natl. Acad. Sci. USA. 89:1992;4977-4981.
128. Yoshida H., Ohagi S., Sanke T., Furuta H., Furuta M., Nanjo K. Association of the prohormone convertase 2 gene (PCSK2) on chromosome 20 with NIDDM in Japanese subjects. Diabetes. 44:1995;389-393.
129. Hotamisligil G.S., Shagill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science. 259:1993;87-91.
130. Nedospasov S.A., Udalova I.A., Kuprash D.V., Turetskaya R.L. DNA sequence polymorphism at the human tumor necrosis factor (TNF) locus. Numerous TNF/lymphotoxin alleles tagged by two closely linked microsatellites in the upstream region of the lymphotoxin (TNF-beta) gene. J. Immunol. 147:1991;1053-1059.
131. Norman R.A., Bogardus C., Ravussin E. Linkage between obesity and a marker near the tumor necrosis factor-α locus in Pima Indians. J. Clin. Invest. 96:1995;158-162.
132. Thoren B. Expression and cloning of the pancreatic β-cell receptor for the glucoincretin hormone glucagon-like peptide-1. Proc. Natl. Acad. Sci. USA. 89:1992;8641-8646.
133. Doria A., Caldwell J.S., Ji L., Reynet D., Rich S.S., Weremowicz S., Morton C.C., Warram J.H., Kahn C.R., Krolewski A.S. Trinucleotide repeats at the rad locus: allele distributions in NIDDM and mapping to a 3-cM region on chromosome 16q. Diabetes. 44:1995;243-247.
134. DeFronzo R.A. Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Rev. 5(3):1997;177-269.
135. DeFronzo R.A., Ferrannini E. Regulation of hepatic glucose metabolism in humans. Diabetes Metab. Rev. 3:1987;415-459.
136. Cherrington A.D., Stevenson R.W., Steiner K.E., Davis M.A., Myers S.R., Adkins B.A., Abumrad N.N., Williams P.E. Insulin, glucagon and glucose as regulators of hepatic glucose uptake and production in vivo. Diabetes Metab. Rev. 3:1987;307-332.
137. Consoli A., Kennedy F., Miles J., Gerich J. Determination of Krebs cycle metabolic carbon exchange in vivo and its use to estimate the individual contributions of gluconeogenesis and glycogenolysis to overall glucose output in man. J. Clin. Invest. 80:1987;1301-1310.
138. Revers R.R., Fik R., Griffin J., Olefsky J.M., Kolterman O.G. Influence of hyperglycemia on insulin's in vivo effects in Type II diabetes. J. Clin. Invest. 73:1984;664-672.
139. Kolterman O.G., Gray R.S., Griffin J., Burstein P., Insel J., Scarlett J.A., Olefsky J.M. Receptor and postreceptor defects contribute to the insulin resistance in non-insulin-dependent diabetes mellitus. J. Clin. Invest. 68:1981;957-969.
140. Ericksson J., Franssila-Kallunki A., Ekstrand A., Saloranta C., Widen E., Schalin C., Groop L. Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N. Engl. J. Med. 321:1989;337-343.
141. Firth R.G., Bell P.M., Marsh H.M., Hansen I., Rizza R.A. Postprandial hyperglycemia in patients with non-insulin-dependent diabetes mellitus: role of hepatic and extrahepatic tissues. J. Clin. Invest. 77:1986;1525-1532.
142. Ferrannini E., Simonson D.D., Katz L.D., Reichard G. Jr., Bevilacqua S., Barrett E.J., Olsson M., DeFronzo R.A. The disposal of an oral glucose load in patients with non-insulin-dependent diabetes mellitus. Metabolism. 37:1988;79-85.
143. Mueckler M. Family of glucose-transporter genes: implications for glucose homeostasis and diabetes. Diabetes. 39:1990;6-11.
144. Bell G.I., Kayano T., Buse J.B., Burant C.F., Takeda J., Lin D., Fukumoto H., Seino S. Molecular biology of mammalian glucose transporters. Diabetes Care. 13:1990;198-208.
145. DeFronzo R.A., Gunnarsson R., Björkman O., Olsson M., Wahren J. Effects of insulin on peripheral and splanchnic glucose metabolism in non-insulin-dependent (Type II) diabetes mellitus. J. Clin. Invest. 76:1985;149-155.
146. Bogardus C., Lillioja S., Stone K., Mott D. Correlation between muscle glycogen synthase activity and in vivo insulin action in man. J. Clin. Invest. 73:1984;1185-1190.
147. Saloranta C., Franssila-Kallunki A., Ekstrand A., Taskinen M.R., Groop L. Modulation of hepatic glucose production by non-esterified fatty acids in Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 34:1991;409-415.
148. Reaven G.M. Banting Lecture 1988: role of insulin resistance in human disease. Diabetes. 37:1988;1595-1607.
149. Yalow R.S., Berson S.A. Plasma insulin concentrations in nondiabetic and early diabetic subjects: determinations by a new sensitive immuno-assay technique. Diabetes. 9:1960;254-260.
150. Reaven G., Miller R. Study of the relationship between glucose and insulin responses to an oral glucose load in man. Diabetes. 17:1968;560-569.
151. DeFronzo R.A., Ferrannini E., Simonson D.C. Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism. 38:1989;387-395.
152. Kosaka K., Hagura R., Kuzuya T. Insulin responses in equivocal and definite diabetes, with special reference to subjects who had mild glucose intolerance but later developed definite diabetes. Diabetes. 26:1977;944-952.
153. Clement K., Pueyo M.E., Vaxillaire M., Rakotoambinina B., Thuillier F., Passa P.H., Froguel P.H., Robert J.J., Velho G. Assessment of insulin sensitivity in glucokinase-deficient subjects. Diabetologia. 39:1996;82-90.
154. Byrne M.M., Sturis J., Fajans S.S., Ortiz F.J., Stoltz A., Stoffel M., Smith M.J., Bell G.I., Halter J.B., Polonsky K.S. Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20. Diabetes. 44:1995;699-704.
155. Polonsky K.S., Sturis J., Bell G.I. Non-insulin-dependent diabetes mellitus: a genetically programmed failure of the beta cell to compensate for insulin resistance. N. Engl. J. Med. 334:1996;777-783.
156. Herman W.H., Fajans S.S., Ortiz F.J., Smith M.J., Sturis J., Bell G.I., Polonsky K.S., Halter J.B. Abnormal insulin secretion, not insulin resistance, is the genetic or primary defect of MODY in the RW pedigree. Diabetes. 43:1994;40-46.
157. Deacon C.F., Schleser-Mohr S., Ballmann M., Willms B., Conlon J.M., Creutzfeldt W. Preferential release of proinsulin relative to insulin in non-insulin-dependent diabetes mellitus. Acta Endocrinol. 119:1988;549-554.
158. Polonsky K.S., Given B.D., Van Cauter E. Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. J. Clin. Invest. 81:1988;442-448.
159. O'Rahilly S., Turner R.C., Matthews D.R. Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. N. Engl. J. Med. 318:1988;1225-1230.
160. DeFronzo R.A., Tobin J.D., Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol. 6:1979;E214-E223.
161. Curry D.L., Bennett L.L., Grodsky G.M. Dynamics of insulin secretion by the perfused rat pancreas. Endocrinology. 83:1968;572-584.
162. Simpson R.G., Benedetti A., Grodsky G.M., Karam J.H., Forsham P.H. Early phase of insulin release. Diabetes. 17:1968;684-692.
163. Cerasi E. Insulin deficiency and insulin resistance in the pathogenesis
164. Efendic S., Grill V., Luft R., Wajngot A. Low insulin response: a marker of pre-diabetes. Adv. Exp. Med. Biol. 246:1988;167-174.
165. Temple R., Clark P.M.S., Hales C.N. Measurement of insulin secretion in type 2 diabetes: problems and pitfalls. Diabetic Med. 9:1992;503-512.
166. Brunzell J.D., Robertson R.P., Lerner R.L., Hazzard W.R., Ensinck J.W., Bierman E.L., Porte D. Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J. Clin. Endocrinol. 46:1976;222-229.
167. Porte D. Jr. β cells in type II diabetes mellitus. Diabetes. 40:1991;166-180.
168. Unger R.H. Glucagon physiology and pathophysiology in the light of new advances. Diabetologia. 28:1985;574-578.
169. Ward W.K., Bolgiano D.C., McKnight B., Halter J.B., Porte D. Jr. Diminished β cell secretory capacity in patients with non-insulin-dependent diabetes mellitus. J. Clin. Invest. 74:1984;1318-1328.
170. Goodner C.J., Walike B.C., Koerker D.J., Ensinck J.W., Brown A.C., Chideckel E.W., Palmer J., Kalnasy L. Insulin, glucagon, and glucose exhibit synchronous, sustained oscillations in fasting monkey. Science. 146:1977;177-179.
171. Lang D.A., Matthews D.R., Peto J., Turner R.C. Cyclic oscillations of basal plasma glucose and insulin concentrations in human beings. N. Engl. J. Med. 301:1979;1023-1027.
172. Gumbiner B., Van Cauter E., Beltz W.F., Ditzler T.M., Griver K., Polonsky K.S., Henry R.R. Abnormalities of insulin pulsatility and glucose oscillations during meals in obese non-insulin-dependent diabetic patients: effects of weight reduction. J. Clin. Endocrinol. Metab. 81:1996;2061-2068.
173. Gerich J.E., Charles M.A., Grodsky G.M. Regulation of pancreatic insulin and glucagon secretion. Annu. Rev. Physiol. 38:1976;353-388.
174. Bolli G.B., Tsalikian E., Haymond M.W., Cryer P.E., Gerich J.E. Defective glucose counterregulation after subcutaneous insulin in non-insulin-dependent diabetes mellitus. J. Clin. Invest. 73:1984;1532-1541.
175. Saito K., Yaginuma N., Takahashi T. Differential volumetry of A, B, and D cells in the pancreatic islets of diabetic and nondiabetic subjects. Tohoku J. Exp. Med. 129:1979;273-283.
176. Westermark P., Wilander E. The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus. Diabetologia. 14:1978;417-421.
177. Cooper G.J.S., Willis A.C., Clark A., Turner R.C., Sim R.B., Reid K.B. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc. Natl. Acad. Sci. USA. 84:1987;8628-8632.
178. Westermark P., Wernstedt C., Wilander E., Hayden D.W., O'Brien T.D., Johnson K.H. Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islets. Proc. Natl. Acad. Sci. USA. 84:1987;3881-3885.
179. Kahn S.E., D'Alessio D.A., Schwartz M.W., Fujimoto W.Y., Ensinck J.W., Taborsky G.J. Jr., Porte D. Jr. Evidence of cosecretion of islet amyloid polypeptide and insulin by β-cells. Diabetes. 39:1990;634-638.
180. Clark A. Islet amyloid and type 2 diabetes. Diabetic Med. 6:1989;561-567.
181. Ward W.K., Wallum B.J., Beard J.C., Taborsky G.J. Jr., Porte D. Jr. Reduction of glycemic potentiation: a sensitive indicator of β-cell loss in partially pancreatectomized dogs. Diabetes. 37:1988;723-729.
182. Savage P.J., Bennion L.O., Flock E.V., Nagulesparan M., Mott D., Roth J., Unger R.H., Bennett P.H. Diet induced improvement of abnormalities in insulin and glucagon secretion and in insulin receptor binding in diabetes mellitus. J. Clin. Endocrinol. Metab. 48:1979;999-1007.
183. Stanik S., Marcus R. Insulin secretion improves following dietary control of plasma glucose in severely hyperglycemic obese patients. Metabolism. 29:1980;346-350.
184. Andrews W.J., Vasquez B., Nagulesparan M., Klimes I., Foley J., Unger R., Reaven G.M. Insulin therapy in obese, non-insulin-dependent diabetes induces improvements in insulin action and secretion that are maintained for two weeks after insulin withdrawal. Diabetes. 33:1981;634-642.
185. Rossetti L., Giaccari A., DeFronzo R.A. Glucose toxicity. Diabetes Care. 13:1990;610-630.
186. Leahy J.L. Natural history of beta cell dysfunction in non-insulin-dependent diabetes mellitus. Diabetes Care. 13:1990;992-1010.
187. Robertson R.P., Olson I.K., Zhang H-J. Differentiating glucose toxicity from glucose desensitization: a new message from the insulin gene. Diabetes. 43:1994;1085-1089.
188. + channel function in perfused rat pancreatic islets. Diabetes. 39:1990;397-399.
189. Thorens B., Wu Y.J., Leahy J.L., Weir G.C. The loss of GLUT-2 expression by glucose-unresponsive beta cells of db/db mice is reversible and is induced by the diabetic environment. J. Clin. Invest. 90:1992;77-85.
190. Unger R.H., Grundy S. Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implication for the management of diabetes. Diabetologia. 28:1985;119-121.
191. Turner R.C., Holman R.R., Matthews D., Hockaday T.D., Peto J. Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. Metabolism. 28:1979;1086-1096.
192. Bergman R.N., Finegood D., Ader M. Assessment of insulin sensitivity in vivo. Endocr. Rev. 6(Suppl.):1985;45-86.
193. Martin B.C., Warram J.H., Krolewski A.S., Gergman R.N., Soeldner J.S., Kahn C.R. Role of glucose and insulin resistance in the development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet. 340:1992;925-929.
194. Saad M.F., Knowler W.C., Pettitt D.J., Nelson R.G., Mott D.M., Bennett P.H. Sequential changes in serum insulin concentration during development of non-insulin-dependent diabetes mellitus. Lancet. I:1989;1356-1359.
195. Warram J.H., Martin B.C., Krolewski A.S., Soeldner J.S., Kahn C.R. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic patients. Ann. Intern. Med. 113:1990;909-915.
196. Lillioja S., Mott D.M., Howard B.V., Bennett P.H., Yki-Järvinen H., Freymond D., Nyomba B.L., Zurlo F., Swinburn B., Bogardus C. Impaired glucose tolerance as a disorder of insulin action: longitudinal and cross-sectional studies in Pima Indians. N. Engl. J. Med. 318:1988;1217-1225.
197. Garvey W.T., Huecksteadt T.P., Matthaei S., Olefsky J.M. Role of glucose transporters in the cellular insulin resistance of type II non-insulin-dependent diabetes mellitus. J. Clin. Invest. 81:1988;1528-1536.
198. Yki-Järvinen H. Role of insulin resistance in the pathogenesis of NIDDM. Diabetologia. 38:1995;1378-1388.
199. Bogardus C., Lillioja S., Howard B., Reaven G., Mott D. Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and non-insulin-dependent diabetic subjects. J. Clin. Invest. 74:1984;1238-1246.
200. Firth R., Bell P., Rizza R. Insulin action in non-insulin-dependent diabetes mellitus: the relationship between hepatic and extrahepatic insulin resistance and obesity. Metabolism. 36:1987;1091-1095.
201. Consoli A., Nurjahn N., Capani F., Gerich J. Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes. 38:1989;550-556.
202. Nurjhan N., Consoli A., Gerich J. Increased lipolysis and its consequences on gluconeogenesis in non-insulin-dependent diabetes mellitus. J. Clin. Invest. 89:1992;169-175.
203. 13C] glucose study. Am. J. Physiol. 270:1996;E709-E717.
204. Butler P.C., Kryshak E.J., Schwenk W.F., Haymond M.W., Rizza R.A. Hepatic and extrahepatic responses to insulin in NIDDM and nondiabetic humans: assessments in absence of artifact introduced by tritiated nonglucose contaminants. Diabetes. 39:1990;217-225.
205. Olefsky J.M., Reaven G.M. Insulin binding in diabetes. Relationships with plasma insulin levels and insulin sensitivity. Diabetes. 26:1977;680-688.
206. DePirro R., Fusco A., Lauro R., Testa I., Ferreti F., DeMartini S.C. Erythrocyte insulin receptors in non-insulin-dependent diabetes mellitus. Diabetes. 29:1980;96-99.
207. Schalin-Jantti C., Harkenen M., Groop L.C. Impaired activation of glycogen synthase in people at increased risk for developing NIDDM. Diabetes. 41:1992;598-604.
208. Kashiwagi A., Verso M.A., Andrews J., Vasquez B., Reaven G., Foley J.E. In vitro insulin resistance of human adipocytes isolated from subjects with non-insulin-dependent diabetes mellitus. J. Clin. Invest. 72:1983;1246-1254.
209. Kahn B.B. Facilitative glucose transporters: regulatory mechanisms and dysregulation in diabetes. J. Clin. Invest. 89:1992;1367-1374.
210. Henry R.R., Abrams L., Nikoulina S., Ciaraldi T.P. Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects. Diabetes. 44:1995;936-946.
211. Ciaraldi T.P., Abrams L., Nikoulina S., Mudaliar S., Henry R.R. Glucose transport in cultured human skeletal muscle cells. J. Clin. Invest. 96:1995;2820-2827.
212. Carey J.O., Azevedo J.L. Jr., Morris P.G., Pories W.J., Dohn G.L. Okadaic acid, vanadate and phenylarsine oxide stimulate 2-deoxyglucose transport in insulin-resistant human skeletal muscle. Diabetes. 44:1995;682-688.
213. Paolisso G., Tataranni P.A., Foley J.E., Bogardus C., Howard B.V., Ravussin E. A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM. Diabetologia. 38:1995;1213-1217.
214. Ferrannini E., Barrett E.J., Bevilacqua S., DeFronzo R.A. Effect of fatty acids on glucose production and utilization in man. J. Clin. Invest. 72:1983;1737-1747.
215. Leahy J.L., Bonner-Weir S., Weir G.C. Beta-cell dysfunction induced by chronic hyperglycemia: current ideas on mechanisms of impaired glucose-induced insulin secretion. Diabetes Care. 15:1992;442-455.
216. Garvey W.T., Olefsky J.M., Mathaei S., Marshall S. Glucose and insulin co-regulate the glucose transport system in primary cultured adipocytes. A new mechanism of insulin resistance. J. Biol. Chem. 262:1987;189-197.
217. Rossetti L., Smith D., Shulman G.I., Papachristou D., DeFronzo R. Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J. Clin. Invest. 79:1987;1510-1515.
218. Matthaei S., Horuk R., Olefsky J.M. Blood-brain glucose transfer in diabetes mellitus. Diabetes. 35:1986;1181-1184.
219. Garvey W.T., Olefsky J.M., Griffin J., Hamman R.F., Kolterman O.G. The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus. Diabetes. 34:1985;222-234.
220. J.K. Davidson, M. DiGirolamo, Non-insulin-dependent diabetes mellitus, in: J.K. Davidson (Ed.), Clinical Diabetes Mellitus: A Problem-Oriented Approach, Theme Medical Publishers, New York, 1991, pp. 11-34.
221. Kissebah A.H., Vydelingum N., Murray R., Evans D.J., Hartz A.J., Kalkhoff R.K., Adams P.W. Relation of body fat distribution to metabolic complications of obesity. J. Clin. Endocrinol. Metab. 54:1982;254-260.
222. Krotkiewski M., Björntorp P., Sjöström L., Smith U. Impact of obesity on metabolism in men and women: importance of regional adipose tissue distribution. J. Clin. Invest. 72:1983;1150-1162.
223. Kolterman O.G., Insel J., Seakow M., Olefsky J.M. Mechanisms of insulin resistance in human obesity: evidence of receptor and postreceptor defects. J. Clin. Invest. 65:1980;1272-1284.
224. Kriska A.M., LaPorte R.E., Pettitt D.J., Charles M.A., Nelson R.G., Kuller L.H., Bennett P.H., Knowler W.C. The association of physical activity with obesity, fat distribution and glucose tolerance in Pima Indians. Diabetologia. 36:1993;863-869.
225. Lohmann D., Liebold F., Heilmann W., Senger H., Pohl A. Diminished insulin response in highly trained athletes. Metabolism. 27:1978;521-524.
226. Bogardus C., Thuillez P., Revussin E., Vasquez B., Narimiga M., Azhar S. Effect of muscle glycogen depletion on in vivo insulin action in man. J. Clin. Invest. 72:1983;1605-1610.
227. Hollenbeck C.B., Reaven G.M. Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J. Clin. Endocrinol. Metab. 64:1987;1169-1173.
228. DeFronzo R.A., Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and ASCVD (review). Diabetes Care. 14:1991;173-194.
229. Kahn S.E., Prigeon R.L., McCullough C.K., Boyko E.J., Bergman R.N., Schwzartz M.W., Neifing J.L., Ward W.K., Beard J.C., Palmer J.P., Porte D. Jr. Quantification of the relationship between insulin sensitivity and β cell function in human subjects: evidence for a hyperbolic function. Diabetes. 42:1993;1663-1672.